Showing results (61-70 of 298) with videos related to
Sort By:
Pageof 30
Evidence-Based Complementary and Alternative Medicine : Ecam|April 29, 2014
Protective effect of danhong injection on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in miceYing Wang, Li-Na Gao, Yuan-Lu Cui, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|June 20, 2015
Comparison of Paeoniflorin and Albiflorin on Human CYP3A4 and CYP2D6Li-Na Gao, Ye Zhang, Yuan-Lu Cui, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|April 23, 2020
Bibliometrics and Visualization of the Mechanisms of Parkinson's Diseases Based on Animal ModelsYan-Qiu Wang, Yi-Bing Chen, Dong Xu, et al.Journal of Biopharmaceutical Statistics|November 27, 2002
Issues related to subgroup analysis in clinical trialsLu Cui, H M James Hung, Sue Jane Wang, et al.Journal of Hazardous Materials|December 22, 2014
Novel reduction of Cr(VI) from wastewater using a naturally derived microcapsule loaded with rutin-Cr(III) complexYun Qi, Meng Jiang, Yuan-Lu Cui, et al.Biomedical and Environmental Sciences : BES|March 16, 2017
Surveys in Areas of High Risk of Iodine Deficiency and Iodine Excess in China, 2012-2014: Current Status and Examination of the Relationship between Urinary Iodine Concentration and Goiter Prevalence in Children Aged 8-10 YearsSi Lu Cui, Peng Liu, Xiao Hui Su, et al.Journal of Biopharmaceutical Statistics|March 15, 2003
Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trialYi Tsong, Sue Jane Wang, H M James Hung, et al.Journal of Biomolecular Structure & Dynamics|July 2, 2015
Molecular dynamics investigations of BioH protein substrate specificity for biotin synthesisQiao Xue, Ying-Lu Cui, Qing-Chuan Zheng, et al.Journal of Biopharmaceutical Statistics|July 19, 2005
Adaptive statistical analysis following sample size modification based on interim review of effect sizeH M James Hung, Lu Cui, Sue-Jane Wang, et al.Expert Opinion on Biological Therapy|September 27, 2016
The design of clinical trials to support the switching and alternation of biosimilarsFreddy Faccin, Paul Tebbey, Emily Alexander, et al.Pageof 30